Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asiros is a Danish biotechnology company specializing in the development and production of high-quality natural ingredients derived from berries and plants. The company utilizes its proprietary BerryShield technology to ensure the stability and bioavailability of bioactive compounds in its products. Asiros focuses on providing science-based solutions for the nutraceutical, functional food, and beverage industries, with a particular emphasis on gut health, immunity, and cognitive function. Their portfolio includes branded ingredients like MitoBeauty and BerryShield powders, which are supported by clinical research and manufactured in their own facilities. The company maintains a strong focus on quality and traceability, managing the entire supply chain from raw material sourcing to final production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asiros.